Sep 29, 2009
IMMUNOVACCINE TECHNOLOGIES (IVT), a vaccine development company based in Halifax, announced Monday that it has appointed Gary Dodge, CA, as chief financial officer. Reporting to president and CEO Dr. Randal Chase, Mr. Dodge will oversee IVT’s accounting and financing activities. He will also becomes a part of the company’s executive management team, which directs all aspects of company strategy, planning and operations.
"We received a lot of interest in the CFO position and met with many impressive candidates," said Dr. Chase. "However, with Gary’s experience in public company reporting, international accounting and financial controls, we knew he would be the right fit."
URL
http://thechronicleherald.ca/Business/1144964.html
Source
Copyright © The Chronicle Herald, September 29th, 2009